Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2228-2247
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Recent advances in targeted therapies in acute myeloid leukemia
Rahul S. Bhansali, Keith W. Pratz, Catherine Lai
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 114
Genetic basis and molecular profiling in myeloproliferative neoplasms
Damien Luque Paz, Róbert Královics, Radek C. Skoda
Blood (2022) Vol. 141, Iss. 16, pp. 1909-1921
Open Access | Times Cited: 78
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease
Wei‐Ying Jen, Hagop M. Kantarjian, Tapan M. Kadia, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 1, pp. 30-47
Open Access | Times Cited: 17
TP53 Mutations in Myeloproliferative Neoplasms: Context‐Dependent Evaluation of Prognostic Relevance
Ayalew Tefferi, Maymona Abdelmagid, Giuseppe Gaetano Loscocco, et al.
American Journal of Hematology (2025)
Open Access | Times Cited: 3
Myelodysplastic syndromes
Huan Li, Fang‐Wen Hu, Robert Peter Gale, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 45
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia
Brunangelo Falini, Maria Paola Martelli
American Journal of Hematology (2023) Vol. 98, Iss. 3, pp. 481-492
Closed Access | Times Cited: 34
Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26
Claire C. Homan, Hamish S. Scott, Anna Brown
Blood (2023) Vol. 141, Iss. 13, pp. 1533-1543
Open Access | Times Cited: 28
Diagnosis and classification of myelodysplastic syndromes
Robert P. Hasserjian, Ulrich Germing, Luca Malcovati
Blood (2023) Vol. 142, Iss. 26, pp. 2247-2257
Closed Access | Times Cited: 23
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1550-1559
Closed Access | Times Cited: 11
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
Martina Ruglioni, Stefania Crucitta, Giovanna Irene Luculli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104424-104424
Open Access | Times Cited: 10
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P. Hasserjian, Peter L. Greenberg, et al.
Blood (2024) Vol. 144, Iss. 15, pp. 1617-1632
Closed Access | Times Cited: 9
Innovative laboratory techniques shaping cancer diagnosis and treatment in developing countries
Azeez Okikiola Lawal, Tolulope Joseph Ogunniyi, Oriire Idunnuoluwa Oludele, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Novel precision medicine approaches and treatment strategies in hematological malignancies
Richard Rosenquist, Elsa Bernard, Tom Erkers, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 413-436
Open Access | Times Cited: 16
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis
Giuseppe Gaetano Loscocco, Giada Rotunno, Francesco Mannelli, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1, pp. 68-78
Open Access | Times Cited: 16
Artificial Intelligence, Lymphoid Neoplasms, and Prediction of MYC, BCL2, and BCL6 Gene Expression Using a Pan-Cancer Panel in Diffuse Large B-Cell Lymphoma
Joaquim Carreras, Naoya Nakamura
Hemato (2024) Vol. 5, Iss. 2, pp. 119-143
Open Access | Times Cited: 6
Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity
Elisabetta Molteni, Elisa Bono, Anna Gallí, et al.
Blood (2023) Vol. 142, Iss. 7, pp. 643-657
Open Access | Times Cited: 14
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group
Bettina Jansko-Gadermeir, Michael Leisch, Franz Josef Gassner, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2305-2305
Open Access | Times Cited: 13
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
Amy M. Trottier, Simone Feurstein, Lucy A. Godley
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 1, pp. 101537-101537
Closed Access | Times Cited: 4
Apport de la cytogénétique dans les hémopathies malignes
Julie Quessada, Florence Nguyen‐Khac
Revue Francophone des Laboratoires (2025) Vol. 2025, Iss. 568, pp. 61-66
Closed Access
A genetikai eredetű gyermekkori krónikus cytopeniák felismerése a molekuláris medicina érájában
Bálint Egyed, Kristóf Árvai, Erik Zajta, et al.
Orvosi Hetilap (2025) Vol. 166, Iss. 1, pp. 3-19
Closed Access
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia
Gloria Hidalgo‐Gómez, Bárbara Tazón‐Vega, Carlos Palacio, et al.
Annals of Hematology (2025)
Open Access
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes
David Rombaut, Sarah Sandmann, Tobias Tekath, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access
Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapies
Uwe Platzbecker, Richard A. Larson, Sandeep Gurbuxani
HemaSphere (2025) Vol. 9, Iss. 2
Open Access
Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies
Melissa Zhao, Scott Ryall, Sam J. Brody, et al.
Blood Advances (2025) Vol. 9, Iss. 5, pp. 1003-1012
Open Access
Repositioning of FDA-approved anti-cancer drugs for fatal blast crisis CML by integrated high-throughput genomic and artificial intelligence-based drug discovery analyses of pan-leukemic genetic abnormalities: Implications in post-COVID-19 era
Zafar Iqbal, Nawaf Alanazi, Sarah AlMukhaylid, et al.
Research Square (Research Square) (2025)
Closed Access
Page 1 - Next Page

Scroll to top